[1] 曾大勇,王长连,黄品芳,等. 别嘌醇引发严重皮肤不良反应标志基因HLA-B*5801的检测方法研究[J].中国现代应用药学,2015,32(6):700-704. [2] 高杰,张晶晶,王进,等.别嘌醇致严重皮肤不良反应与江苏汉族人HLA-B*5801等位基因的相关性研究[J].药物不良反应杂志,2013,10(15):258-259. [3] Cao Z H,Wei Z Y,Zhu Q Y,et al.HLA-B*5801 allele is associated with augmented risk for both mild and severe cutaneous adverse reation induced by allopurinol in Han Chinese[J]. Pharmacogenomics, 2012, 13(10):1193-1201. [4] Jung J W,Song W J,Kim Y S,et al.HLA-B58 can help the clinical decision on starting allopurinol in patients with chronic renalinsufficiency[J]. Nephrol Dial Transplant,2011,26(11):3567-3572. [5] Ramasamy S N,Korb-Wells C S,Kannangara D R,et al. Allopurinol hypersensitivity:a systematic review of all published cases,1950-2012[J]. Drug Saf,2013,36(10):953-980. [6] Chung W H,Hung S I,Hong H S, et al.A marker for Stevens-Johnson syndrome[J]. Nature,2004,428(6982):248-486. [7] Khanna D,Fitzgerald J D,Khanna P P,et a1.2012 American college of rheumatology guidelines for management of gout. Part 1:systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia[J]. Arthritis Care Res(Hoboken),2012,64(10):1431-1446. [8] 云雄,吴丹娜,韩方璇,等.海南省汉族人群HLA-B*5801基因多态性与别嘌醇所致不良反应的相关性研究[J].中国药房,2018,29(9):1256-1259. [9] 罗阳,韩悦,王宝玺,等.别嘌醇引起发疹型药疹8例及相关基因HLA-B*5801检测[J].中华临床免疫和变态反应杂志,2016,10(2):87-90. [10] Kannangara D R,Ramasamy S N,Ray J E,et al.An audit of a therapeutic drug monitoring service for allopurinol therapy[J]. Ther Drug Monit,2013,35( 6) : 863-866. [11] Thurston M M,Phillips B B,Bourg C A.Safety and efficacy of allopurinol in chronic kidney disease[J]. Ann Pharmacother,2013,47(11) : 1507-1516. [12] Yeo S I.HLA-B* 5801: utility and cost-effectiveness in the Asia-Pacific Region[J]. Int J Rheum Dis,2013,16( 3) : 254-257. |